医学
围手术期
入射(几何)
临床终点
不利影响
结直肠癌
外科
内科学
临床试验
化疗
阶段(地层学)
辅助化疗
病态的
随机对照试验
肿瘤科
癌症
临床研究阶段
普通外科
回顾性队列研究
作者
Ryosuke Mizuno,Rei Mizuno,Ryosuke Okamura,Ryo Takahashi,Daisuke Ito,Satoshi Nagayama,Tomoaki Okada,Kenjiro Hirai,Takehito Yamamoto,Kenji Kawada,Nobu Oshima,Teppei Murakami,Takamasa S. Yamamoto,Ben Sasaki,Ryo Matsusue,Yoshinori Hirasaki,Keita Hanada,Kentaro Ueno,Yuki Nakanishi,Junichi Matsubara
出处
期刊:Future Oncology
[Future Medicine]
日期:2026-01-04
卷期号:22 (3): 299-304
被引量:2
标识
DOI:10.1080/14796694.2025.2610466
摘要
AIMS: Self-expanding metal stents (SEMS) are widely used as a bridge to surgery in obstructive colon cancer, offering short-term benefits by reducing postoperative complications and avoiding emergency stoma creation. Additionally, early initiation of systemic chemotherapy may improve oncological outcomes. However, the safety and feasibility of preoperative chemotherapy following SEMS placement remain unclear. This study aims to evaluate the safety and efficacy of neoadjuvant CAPOX chemotherapy after SEMS placement in patients with obstructive colon cancer. PATIENTS & METHODS: This is a prospective, multicenter, single-arm Phase II trial involving patients with clinical stage II or III obstructive colon cancer. Eligible patients undergo successful SEMS placement followed by two cycles of CAPOX chemotherapy prior to elective surgery. The primary endpoint is the incidence of severe perioperative complications, defined as a composite of stent-related adverse events and Clavien - Dindo Grade III or higher postoperative complications. Secondary endpoints include chemotherapy-related adverse events, pathological response, and 2-year relapse-free survival. A total of 75 patients are planned for enrollment across 16 hospitals in Japan over 1.5 years. The study is registered in the Japan Registry of Clinical Trials (jRCTs051240077).
科研通智能强力驱动
Strongly Powered by AbleSci AI